WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007002571) USE OF AN ANTI C5 COMPLEMENT ANTIBODY TO TREAT PATIENTS WITH SICKLE CELL DISEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/002571    International Application No.:    PCT/US2006/024770
Publication Date: 04.01.2007 International Filing Date: 23.06.2006
IPC:
A61K 39/395 (2006.01), A61P 7/06 (2006.01), C07K 16/18 (2006.01)
Applicants: ALEXION PHARMACEUTICALS, INC. [US/US]; 352 Knotter Drive, Cheshire, CT 06410 (US) (For All Designated States Except US).
ROTHER, Russell [US/US]; (US) (For US Only)
Inventors: ROTHER, Russell; (US)
Agent: VARMA, Anita; Fish & Neave IP Group, Ropes & Gray LLP, One International Place, Boston, MA 02110-2624 (US)
Priority Data:
60/693,473 23.06.2005 US
Title (EN) USE OF AN ANTI C5 COMPLEMENT ANTIBODY TO TREAT PATIENTS WITH SICKLE CELL DISEASE
(FR) UTILISATION D'UN INHIBITEUR DU COMPLEMENT POUR TRAITER DES PATIENTS ATTEINT DE DREPANOCYTOSE
Abstract: front page image
(EN)A method of treating a sickle cell patient with an anti C5 complement antibody is disclosed. Treatment with said antibody decreases the extent of red blood cell lysis and decreases the consequential clinical sequelae.
(FR)L'invention concerne un procédé servant à traiter un patient atteint de drépanocytose au moyen d'un inhibiteur du complément. Le traitement au moyen d'un inhibiteur de l'activation du complément diminue l'étendue de la lyse des globules rouges et réduit les séquelles cliniques résultantes.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)